“Quality of Life in Patients with Bardet-Biedl Syndrome in a Setmelanotide Phase 3 Trial“ 
Elizabeth Forsythe, Ph.D., Great Ormond Street Institute of Child Health, Faculty of Population Health Sciences, University College London 
Poster 

“Efficacy and Safety of Open-Label Setmelanotide in Bardet-Biedl Syndrome: A Phase 3 Trial“ 
Robert Haws, M.D., Clinical Research Center at the Marshfield Clinic Research Institute 
Oral presentation slides 

“Effects of Setmelanotide on Obesity, Hunger, and Safety in SRC1 Insufficiency“ 
Sadaf Farooqi, PhD, Wellcome-MRC Institute of Metabolic Science and NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK  
Poster 

“Effects of Setmelanotide on Obesity, Hunger, and Safety in SH2B1 Deficiency: A Phase 2 Trial“ 
Jesús Argente, M.D., Ph.D., Professor in the Department of Pediatrics and Pediatric Endocrinology, Universidad Autónoma de Madrid in Spain 
Poster 

“Frequency of MC4R pathway variants in a large US cohort of patients with severe obesity“ 
Ida Moeller, ScD, ScM, MMSc, Director of Biomedical Informatics at Rhythm 
Poster 

“Uncovering Rare Obesity Genetic Testing Program: Overview and Health Care Provider Utilization“ 
Jill Garrison, Ph.D., Associate Director, Medical Affairs, at Rhythm 
Poster 

“Biochemical Characterization of Single Minded-1 Missense Variants Associated with Severe Obesity“ 
Megan Vogel, Ph.D., Scientist, Pre-Clinical Biology at Rhythm 
Poster